Literature DB >> 7327697

Effect of staphylococcal alpha-toxin on neutrophil migration and adhesiveness.

D J Schmeling, C G Gemmell, P R Craddock, P G Quie, P K Peterson.   

Abstract

The effect of staphylococcal alpha-toxin on the chemotactic response of human polymorphonuclear leukocytes was studied by measuring the migration of alpha-toxin-treated cells either through membrane filters toward C5a or under agarose toward N-formyl-l-methionyl-l-phenylalanine. At doses of greater than or equal to 5 hemolytic units, alpha-toxin depressed chemotactic responsiveness in both best systems. Further studies revealed that alpha-toxin was also a potent granulocyte aggregant at doses similar to those necessary for depressed chemotactic capacity. It is proposed that the inhibitory effect of this membrane-active toxin on chemotactic function may be related to increased granulocyte adhesiveness and that the pathogenic properties of alpha-toxin may in part by explained by these effects.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7327697     DOI: 10.1007/bf00911095

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  23 in total

Review 1.  The hemolysins of Staphylococcus aureus.

Authors:  G M Wiseman
Journal:  Bacteriol Rev       Date:  1975-12

2.  Leucocidal effect of staphylococcal delta-lysin.

Authors:  A W JACKSON; R M LITTLE
Journal:  Can J Microbiol       Date:  1957-02       Impact factor: 2.419

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value.

Authors:  D E Hammerschmidt; L J Weaver; L D Hudson; P R Craddock; H S Jacob
Journal:  Lancet       Date:  1980-05-03       Impact factor: 79.321

Review 5.  Complement-induced granulocyte aggregation: an unsuspected mechanism of disease.

Authors:  H S Jacob; P R Craddock; D E Hammerschmidt; C F Moldow
Journal:  N Engl J Med       Date:  1980-04-03       Impact factor: 91.245

6.  Chemotaxigenesis by encapsulated Staphylococcus aureus M.

Authors:  D J Schmeling; P K Peterson; I M Barr; Y Kim; P G Quie
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

7.  Chemotaxigenesis by cell surface components of Staphylococcus aureus.

Authors:  D J Schmeling; P K Peterson; D E Hammerschmidt; Y Kim; J Verhoef; B J Wilkinson; P G Quie
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

8.  Studies of the Biologic Activity of Purified Staphylococcal Alpha-Toxin: I. The Effect of Alpha-Toxin on Cells in Tissue Culture.

Authors:  M S Artenstein; M A Madoff; L Weinstein
Journal:  Yale J Biol Med       Date:  1963-04

9.  Kinetics of phagocytosis and bacterial killing by human polymorphonuclear leukocytes and monocytes.

Authors:  P K Peterson; J Verhoef; D Schmeling; P G Quie
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

10.  Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis.

Authors:  P R Craddock; J Fehr; K L Brigham; R S Kronenberg; H S Jacob
Journal:  N Engl J Med       Date:  1977-04-07       Impact factor: 91.245

View more
  3 in total

1.  Inhibition of in vivo neutrophil accumulation by stress. Possible role of neutrophil adherence.

Authors:  A G Harmsen; T H Turney
Journal:  Inflammation       Date:  1985-03       Impact factor: 4.092

2.  Effect of staphylococcal alpha-toxin on phagocytosis of staphylococci by human polymorphonuclear leukocytes.

Authors:  C G Gemmell; P K Peterson; D J Schmeling; P G Quie
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

3.  Interference with granulocyte function by Staphylococcus epidermidis slime.

Authors:  G M Johnson; D A Lee; W E Regelmann; E D Gray; G Peters; P G Quie
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.